Adipocyte peroxisome proliferator activated receptor-gamma (PPARγ) is the molecular target of thiazolidinediones (TZDs)-based drugs, regulating the transcription level of insulin-responsive genes to enhance insulin sensitivity in peripheral tissues in T2DM (Ahmadian et al., 2013). The gene discussed is INS; the disease is type 2 diabetes mellitus.